Literature DB >> 12082552

Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

N Lale Satiroglu Tufan1, Zhaorui Lian, Jie Liu, Jingbo Pan, Patrick Arbuthnot, Michael Kew, Marcy M Clayton, Minghua Zhu, Mark A Feitelson.   

Abstract

Hepatitis B virus encoded X antigen (HBxAg) may contribute to the development of hepatocellular carcinoma (HCC) by up- or downregulating the expression of cellular genes that promote cell growth and survival. To test this hypothesis, HBxAg-positive and -negative HepG2 cells were constructed, and the patterns of cellular gene expression compared by polymerase chain reaction select cDNA subtraction. The full-length clone of one of these upregulated genes (URG), URG4, encoded a protein of about 104 kDa. URG4 was strongly expressed in hepatitis B-infected liver and in HCC cells, where it costained with HBxAg, and was weakly expressed in uninfected liver, suggesting URG4 was an effector of HBxAg in vivo. Overexpression of URG4 in HepG2 cells promoted hepatocellular growth and survival in tissue culture and in soft agar, and accelerated tumor development in nude mice. Hence, URG4 may be a natural effector of HBxAg that contributes importantly to multistep hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082552      PMCID: PMC1531705          DOI: 10.1038/sj.neo.7900241

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  47 in total

1.  The X protein of hepatitis B virus coactivates potent activation domains.

Authors:  I Haviv; D Vaizel; Y Shaul
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

2.  Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.

Authors:  J Benn; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

3.  Functional inactivation but not structural mutation of p53 causes liver cancer.

Authors:  H Ueda; S J Ullrich; J D Gangemi; C A Kappel; L Ngo; M A Feitelson; G Jay
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

4.  Expression of the pancreatic secretory trypsin inhibitor gene in the liver infected with hepatitis B virus.

Authors:  Y Ohmachi; A Murata; T Yasuda; K Kitagawa; S Yamamoto; M Monden; T Mori; N Matsuura; K Matsubara
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

5.  Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade.

Authors:  J Benn; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

6.  Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.

Authors:  Q Su; Y F Liu; J F Zhang; S X Zhang; D F Li; J J Yang
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

7.  Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.

Authors:  P Paterlini; K Poussin; M Kew; D Franco; C Brechot
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

Review 8.  Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis.

Authors:  W H Caselmann
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

9.  Hepatitis B virus transactivator protein X interacts with the TATA-binding protein.

Authors:  I Qadri; H F Maguire; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation.

Authors:  J H Cheong; M Yi; Y Lin; S Murakami
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more
  26 in total

1.  Segregation analysis of hepatocellular carcinoma in a moderately high-incidence area of East China.

Authors:  Ru-Lin Cai; Wei Meng; Hong-Yan Lu; Wen-Yao Lin; Feng Jiang; Fu-Min Shen
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

2.  Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells.

Authors:  Veli Çıtışlı; Yavuz Dodurga; Canan Eroğlu; Mücahit Seçme; Çığır Biray Avcı; N Lale Şatıroğlu-Tufan
Journal:  Tumour Biol       Date:  2015-04-03

3.  Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.

Authors:  Yavuz Dodurga; Gulsah Gundogdu; Volkan Tekin; Tugba Koc; N Lale Satiroglu-Tufan; Gulseren Bagci; Vural Kucukatay
Journal:  Mol Biol Rep       Date:  2014-03-21       Impact factor: 2.316

4.  Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation.

Authors:  Almut Dufner; Scott Pownall; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

5.  Enhanced cell survival of gastric cancer cells by a novel gene URG4.

Authors:  Jiugang Song; Huahong Xie; Zhaorui Lian; Guitao Yang; Rui Du; Yulei Du; Xue Zou; HaiFeng Jin; Juan Gao; Jie Liu; Daiming Fan
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

6.  Investigation of microRNA expression changes in HepG2 cell line in presence of URG4/URGCP and in absence of URG4/URGCP suppressed by RNA interference.

Authors:  Yavuz Dodurga; G Nilufer Yonguc; Cigir Biray Avci; Gulseren Bagci; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

7.  Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis.

Authors:  Zhaorui Lian; Jie Liu; Li Li; Xianxing Li; N Lale Satiroglu Tufan; Marcy Clayton; Meng-Chao Wu; Hong-Yang Wang; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

8.  CARD6 is interferon inducible but not involved in nucleotide-binding oligomerization domain protein signaling leading to NF-kappaB activation.

Authors:  Almut Dufner; Gordon S Duncan; Andrew Wakeham; Alisha R Elford; Håkan T Hall; Pamela S Ohashi; Tak W Mak
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

9.  Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.

Authors:  Kyoungsub Song; Chang Han; Jinqiang Zhang; Dongdong Lu; Srikanta Dash; Mark Feitelson; Kyu Lim; Tong Wu
Journal:  Hepatology       Date:  2013-09-17       Impact factor: 17.425

10.  The expression of URGCP gene in prostate cancer cell lines: correlation with rapamycin.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; Sunde Yılmaz Susluer; N Lale Satıroğlu Tufan; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2012-09-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.